All posts by imreal

With Minutes Between Life and Death, Continuous Remote ECG Monitoring Saves Lives


News Image

Cardiac care should follow the patient on a virtual journey and deliver high-fidelity insights to care providers, eliminating the gaps in data transmission

Heart disease is the number one killer in the U.S., and high-fidelity monitoring is the beginning of new prospects for patients with congestive heart failure (CHF). Nearly five million Americans of all ages have been diagnosed with CHF, with approximately 550,000 new cases a year.(1) Stuart Long, CEO of InfoBionic says, “Cardiac care should follow the patient on a virtual journey and deliver high-fidelity insights to care providers, eliminating the gaps in data transmission.”

CHF is an imbalance in the heart’s pump function. It is a common clinical syndrome that is a significant public health problem,(2) contributing to the equivalent of one death every 90 seconds.(3) More than half of patients with CHF die within five years of diagnosis, and sudden death occurs 6 to 9 times as often among patients with CHF than in the general population.(1)

Monitoring patients with CHF is critical because, in the case of sudden cardiac arrest (SCA), time to defibrillation is a matter of life and death.(2) For every minute a patient waits for defibrillation, their chances of survival decrease 7 to 10 times.(3) Patients who receive defibrillation within two minutes after SCA have the best chance of survival. However, paramedics take an average of 9.8 minutes to arrive.(3) Reducing time to defibrillation is particularly critical because 75% to 80% of SCAs outside of a hospital happen at home.(4)

One effective solution for patients with CHF is continuous remote cardiac monitoring. It alerts the medical team in advance of SCA, thereby increasing the patient’s chances of survival. Early efforts at remote monitoring relied heavily on a patient’s participation and showed limited success. Emerging technologies using a machine learning algorithm that stream data, detected precursors of heart failure with 76% to 88% sensitivity.(5)

Virtual cardiac telemetry is a practical, noninvasive diagnostic tool. It can detect SCA early and improve the time to defibrillation. It aids in identifying deteriorating and life-threatening conditions such as non-sustained arrhythmias. It facilitates the management of arrhythmias and helps guide patient health management by identifying the cause of symptoms.(6)

Infobionic’s cutting-edge solutions have nearly eliminated this communication gap. InfoBionic’s Platform allows the doctor to set customizable alerts. They can also easily and quickly scroll through the minutes and hours before and after a known cardiac event to identify the acute onset and offset data.

For patients with CHF, any undiscovered dangerous arrhythmia leaves them vulnerable. A significant problem with most monitoring equipment is that they do not alert the physician to essential biotelemetry. Instead, the physician receives 20- to 30-second electrocardiogram (ECG) strips, leaving 95% or more data lost in transmission.(7)

Physicians can now receive full-disclosure data from noninvasive heart monitors directly to their mobile devices throughout an extended monitoring period. This access to data during vital monitoring periods is a game-changer.

The legacy monitors physicians have relied on for years require the patient to return the monitor to the physician’s office or mail it back to a third-party service provider. The patient and provider wait for results — sometimes delayed by weeks — while the third party performs the analysis. This delay puts the patient at risk and fails to give the cardiologist control over the patient’s data review, timing, diagnosis, and care.

InfoBionic’s MoMe Kardia system is the first comprehensive, cloud-based remote patient monitoring platform that delivers on-demand, actionable monitoring data and analytics directly to physicians. This cardiac remote patient monitoring revolutionizes the efficiency and quality of data they have to monitor patients and catch abnormal heart rhythms and cardiac symptoms before they turn deadly.

Long states, “A higher quality system and greater diagnostic yield coupled with state-of-the-art AI will allow for better implementation with improved clinician impacts to staffing and workflow versus traditional systems.”

About InfoBionic

InfoBionic’s digital technology has transformed the efficiency and economics of cardiac remote patient monitoring. The company’s MoMe™ARC platform has removed the roadblocks hindering remote diagnosis and decision-making. The Massachusetts-based team of seasoned entrepreneurs have had successful careers in healthcare, IT, medical devices, mobile technology, and bring specific expertise in remote monitoring and cardiology. More recently, working side by side with the healthcare and medical technology communities, including its own competitors, InfoBionic has developed MoMe®Now, the first virtual telemetry system for high-acuity patients in the remote, virtual, or hospital-at-home care environments. Visit https://InfoBionic.com/.

References: 

1) Emory Healthcare. “Heart Failure Statistics.” Accessed November 14, 2022, Wellness, emoryhealthcare.org/centers-programs/heart-vascular-center/wellness/heart-failure-statistics.html.

2) Gensini, Gian Franco; Alderighi, Camilla; Rasoini, Raffaele; Mazzanti, Marco; Casolo, Giancarlo. “Value of Telemonitoring and Telemedicine in Heart Failure Management.” November 2017, National Library of Medicine, ncbi.nlm.nih.gov/pmc/articles/PMC5739893/

3) Berkman, Meir. “Why Is Rapid Defibrillation Important.” Avive. Accessed November 14, 2022. avive.life/guides/importance-of-time-to-defibrillation/

4) McRae, Tagni. “CPR Facts and Statistics .” Accessed November 14, 2022, American Heart Association, zoll.com/-/media/uploadedfiles/public_site/core_technologies/real_cpr_help/cpr-fakten-pdf.

5) Mohebali D, Kittleson MM. “Remote monitoring in heart failure: current and emerging technologies in the context of the pandemic.” Heart, 2021;107:366-372. heart.bmj.com/content/107/5/366

6) Zègre-Hemsey, Jessica K. PhD, RN; Garvey, J. Lee MD; Carey, Mary G. PhD, RNc. “Cardiac Monitoring in the Emergency Department.” Crit Care Nurs Clin North Am, July 2, 2016. ncbi.nlm.nih.gov/pmc/articles/PMC5630152/

7) Long, Stuart; Movsowitz, Colin M.D. “New Technology Allows Direct Transmission of Remote Cardiac Monitoring Data.” DAIC, August 30, 2019. dicardiology.com/article/new-technology-allows-direct-transmission-remote-cardiac-monitoring-data

Share article on social media or email:

BrightStar Care® Senior Vice President of Marketing Teresa Celmer Recognized as one of Entrepreneur’s 2023 CMO Game Changers


News Image

BrightStar Care Senior Vice President of Marketing Teresa Celmer was recognized as one of the 50 CMO Game Changers in the franchise industry by Entrepreneur. The list, which was unveiled on Entrepreneur.com, highlights the most influential men and women in the franchising industry who are representative of the all-important marketing role.

“We are so very proud of Teresa for ranking on this prestigious list. She is more than deserving of this honor for her incredible work leading marketing and communications efforts for the BrightStar Care brand,” said Shelly Sun, CEO and Founder of BrightStar Care. “Teresa is an innovative, tenacious leader dedicated to the success of our national strategy while concurrently committed to the prosperity of our franchisees’ local marketing efforts. Over the years, we have announced several partnerships, data studies, and growth milestones, and Teresa has led the charge every step of the way to garner the highest reach and awareness for our campaigns.”

Entrepreneur’s first-ever CMO Game Changers list recognizes the C-suite individuals who are changing the game in franchise marketing through innovation, inspiring leadership, personal connections, and growing their brands. Nominees were submitted by their peers. The editors then reviewed and researched the nominations to select the 50 who they highlighted as having an impact at their company and in the franchise marketing space. To be considered, nominees needed to work at a franchisor with more than eighty locations, have worked in the industry for more than three years, and have an executive title in marketing and/or communications.

“We felt it was time to highlight one of the most challenging and important roles in the industry as chief marketers in the franchising industry need to have a thorough understanding of their B2B target market, as well as their B2C target market,” said Entrepreneur Senior Vice President of Franchising Liane Caruso. “The 50 CMOS selected to our inaugural CMO Game Changers represent the innovations, passion, and strategic vision that helps their brands stay competitive in a very competitive business environment.”

To view BrightStar Care’s Teresa Celmer on Entrepreneur’s 2023 CMO Game Changers list, visit entrepreneur.com.

About BrightStar Care

Founded in 2002, BrightStar Care is a national home care franchise with more than 365 locations nationwide that provides medical and non-medical in-home care services to clients in their homes and supplemental care staff to businesses. BrightStar Care franchise agencies across the country employ over 15,000 caregivers and 5,700 registered nurses who oversee the care and safety of each individual client. BrightStar Care offers custom medical staffing solutions to corporate entities and holds national accounts with government agencies across distinct patient populations providing healthcare staff anywhere care is needed. Female founded and led by CEO Shelly Sun, BrightStar Care is committed to providing a higher standard of care through its clinical nurse-led care model. As a member of Moving Health Home, BrightStar Care also actively advocates to change federal and state policies that prevent the home from being an accredited clinical care site. More than 95% of BrightStar Care agencies are Joint Commission accredited – the gold standard within the health care industry. BrightStar Care has also been the only national home care franchise to consecutively receive The Joint Commission’s Enterprise Champion for Quality award for the past decade. For more on BrightStar Care franchising opportunities visit, www.brightstarfranchising.com.

Share article on social media or email:

Aqua-Tots Swim Schools Opens 130th Indoor Learn-to-Swim Facility in Sandy Springs, Georgia


Aqua-Tots Swim Schools is now open in Sandy Springs, Georgia, serving families in north Atlanta with year-round swim lessons for children as early as four months old.

Many people ask about starting swim lessons in the winter, and we remind them that now is the best time to start their journey toward safe and confident swimming before summer. -Jesse Rhodenbaugh, Franchise Owner

Aqua-Tots Swim Schools, the largest international swim school franchise, announces the opening of their 130th worldwide location in Sandy Springs, Georgia. Located at 5290 Roswell Rd. at the intersection of Roswell and Mt. Paran Roads, Aqua-Tots Sandy Springs opened to the community on Monday, December 5, 2022.

Aqua-Tots Sandy Springs is the eighth Atlanta-area school and the thirteenth location for business partners, Andrew George, Jesse Rhodenbaugh and Tommy Fisher, who also own schools in North Carolina and Virginia. Upon opening the state-of-the-art 6,300 square foot facility, the team at Aqua-Tots will be ready to serve families in the Atlanta, Sandy Springs and Buckhead communities.

“We’ve always loved the families of Atlanta, and our new location in Sandy Springs gives us an opportunity to reach even more children with lifesaving swim lessons,” said Rhodenbaugh. “Many people ask about starting swim lessons in the winter, and we remind them that now is the best time to start their journey toward safe and confident swimming before summer.”

According to the Centers for Disease Control and Prevention, drowning is the leading cause of unintentional, injury-related death in children one to four years old. Drowning prevention education is vital year-round as 69% of children were not expected to be in or near a pool at the time of a drowning incident.

The National Institutes of Health also states that participation in formal swim lessons can reduce the risk of drowning by 88% among children ages one to four years, and the Aqua-Tots Swim Journey is comprised of eight levels of proven curriculum that is trusted all over the world to teach more than five million swim lessons every year.

Aqua-Tots Sandy Springs is now open Monday through Saturday, and for a limited time, families can lock in founder’s pricing for as long as they are enrolled in lessons (a savings of $20/month). Families can reserve a spot in small group (4:1 ratio), semi-private (2:1 ratio) or private (1:1 ratio) lessons before classes fill up. Aqua-Tots Sandy Springs also features the Special Needs Aquatic Program (S.N.A.P.), Fast Track and adult swim lessons.

Aqua-Tots Sandy Springs is now hiring swim instructors. No experience is needed, and all positions include paid training. For more information and to apply online, visit aqua-tots.com/sandy-springs/employment or email a resume to sandyspringsgm@aqua-tots.com.

To learn more about Aqua-Tots Sandy Springs or to sign up for swim lessons, visit aqua-tots.com/sandy-springs.

About Aqua-Tots Swim Schools

Founded in 1991 and headquartered in the Phoenix area, Aqua-Tots Swim Schools is making waves as the largest international provider of year-round, indoor swim instruction, community outreach, and drowning prevention education. Its trusted program is dedicated to children of all abilities from four months to 12 years old and features a proven curriculum used to teach more than five million swim lessons each year.

Recognized in Entrepreneur’s Franchise 500®, Inc. Magazine’s Top 5000 and Franchise Times’ Top 200, Aqua-Tots has more than 130 locations in 25 states across 14 countries and is rapidly expanding with 90 locations in development. To learn more about franchise opportunities, visit aqua-tots.com/franchise-development and for more information about Aqua-Tots or to sign up for lessons near you, visit aqua-tots.com or follow Aqua-Tots on Facebook and Instagram.

Share article on social media or email:



Formation Venture Engineering Successfully Exits its Investment in Cell IDx


News Image

Formation Venture Engineering (FVE) identifies, builds, and manages investments into pre-seed, seed, and startup-stage companies that are at the vanguard of change within healthcare and the life sciences industry.

Leica Biosystems has acquired Cell IDx Inc., a technology leader in multiplexed tissue profiling, developing highly sensitive and specific chromogenic and fluorescent multiplex immunohistochemistry reagents to meet the needs of precision medicine. The acquisition is timed with the planned exit of Cell IDx from the Formation Venture Engineering portfolio.

“We believe Leica Biosystems recognized that Cell IDx’s technology takes cancer pathology screening to a new level, generating a multiplex, color-coded profile that adds breadth and specificity of information enabling more robust diagnosis by pathologists, without changing workflows,” said Rahul Bhansali, cofounder and Managing Partner of Formation Venture Engineering. “Cell IDx technology has the potential to significantly reduce the time taken to, and increase the fidelity of, cancer diagnosis and the diagnosis of a range of diseases, helping to ease the suffering of millions of patients around the world. Now that Leica Biosystems, a world leader in workflow solutions and automation for pathology laboratories and researchers, has acquired this game-changing technology 25 months after our first investment, we look forward to seeing increased utilization for patients’ benefit around the world.”

“We are thrilled to welcome Cell IDx to the Leica Biosystems team,” said Gustavo Perez-Fernandez, President of Leica Biosystems, in a recent press release. “This acquisition will expand our capabilities in the translational research segment and help researchers to accelerate their journey, transforming scientific exploration into translational outcomes.”

“Cell IDx is thrilled to be acquired by Leica Biosystems,” said David Schwartz, CEO and founder of Cell IDx, Inc. “The synergies between the two companies foreshadows successful commercialization for both clinical and research products developed by Cell IDx’s proprietary multiplex technology. I would like to thank FVE for their belief in our team, the venture engineering guidance provided, and financial support that was crucial to allow us to attract an acquirer like Leica Biosystems.”

Cell IDx’s planned exit is part of a core strategy for its largest institutional investor, the venture capital firm Formation Venture Engineering (FVE). FVE has built a fundamentally novel capitalization approach, investing in transformative platform technology companies in the life sciences, starting with the exit in sight. The venture engineering approach utilizes truth-seeking principles to ensure market pull and engineers the companies to accelerated exits and inherent momentum for rapid scaling.

Formation Venture Engineering (FVE) identifies, builds, and manages investments into pre-seed, seed, and startup-stage companies that are at the vanguard of change within healthcare and the life sciences industry. FVE’s process efficiently creates value and planned exits that are intentionally swift. The sale of Cell IDx just 25 months after initial investment followed FVE’s venture engineering process, which is unique within the venture capital industry.

“We are activating the world’s largest, most potent human problem-solving potential, by unlocking the way scientific innovation makes it to the market. Following humble truth finding and principles of parity, we believe investors, inventors, and the world will benefit. With the sale of Cell IDx, we’ve demonstrated the veracity of our approach and advanced our goals of impacting human health and rewarding our investors,” said Bhansali.

About Formation Venture Engineering

Formation Venture Engineering’s (FVE) mission is to reduce human suffering while creating financial value, for the benefit of the world. By recognizing the common pitfalls of building ventures and aligning stakeholders, FVE’s model positions its funds to deliver uncommonly reliable venture-level returns for enormous benefit to its founders and investors. After proving the concept and defining the exit, FVE builds teams from industry powerbrokers, in alignment with acquirers, to enable realization with high-value, planned exits. More at http://www.formationve.com.

Share article on social media or email:

WANRack Announces Expansion in the State of Virginia- Bringing Better Broadband to the Hampton City Community


News Image

“Hampton City Schools looks forward to this partnership with WANRack in order to provide our community with a state-of-art fiber optic network for our schools,” shares John Eagle, director of information technology for Hampton City Schools.

WANRack adds another school district to its Virginia portfolio. During the 2022 E-Rate Funding Year, Hampton City Schools selected WANRack to design, build and install a new, leased lit private fiber-wide area network. This network will canvass every corner of the Hampton area to connect 32 schools and centers serving over 22,000 students & staff with better broadband access. The network will also pass by many anchor institutions such as libraries, hospitals, city buildings, and county sites allowing for ultra high speed broadband throughout the community.

“The City of Hampton is a future forward-thinking city,” said Rob Oyler, CEO of WANRack. “This middle-mile network now allows the entire city to capitalize on the unprecedented broadband growth WANRack provides and now will help leverage federal last-mile grant dollars in the future.” The WANRack network solution will provide the district with faster bandwidth speeds, more robust security, and substantial cost savings, while delivering unlimited growth for the life of the network.

Upgrading to the WANRack network solution lowers the district’s monthly charges by more than 50%. In addition, the new network eliminates hundreds of thousands of dollars in expenses that the district would have incurred with traditional providers as their bandwidth increases over time. WANRack fiber networks guarantee a future-proof approach so districts can get ahead of their future networking needs. The district can upgrade and increase bandwidth anytime during its contract, with little to no expense.

WANRack and the district are working closely together on engineering and designing the network. Construction of the new network is estimated to start in Spring 2023 and conclude by January of 2024.

“Hampton City Schools looks forward to this partnership with WANRack in order to provide our community with a state-of-art fiber optic network for our schools,” shares John Eagle, director of information technology for Hampton City Schools.

About WANRack

WANRack provides high-bandwidth, fiber-based communications networks and related services to customers throughout the continental United States. Service offerings include E-Rate-compliant lit fiber, dark fiber, and special construction solutions. Headquartered in Lenexa, Kansas, the company provides point-to-point fiber networks, which eliminate countless points of failure found in traditional legacy networks. To learn more about WANRack, visit http://www.wanrack.com.

For more information, call Macie Heller at (913) 909-5491, or email macie.heller@wanrack.com.

Share article on social media or email:

Caring Transitions of Costa Mesa Increasing Accessibility of Much-Needed Services to Orange County


“We’re here to simplify the process and keep our customers from feeling overwhelmed by the task at hand.”

Caring Transitions, the leader in senior relocation and transition services, continues to expand its compassionate reach across the nation with its latest location. Caring Transitions of Costa Mesa is owned and operated by Kevin and Jennifer Dixon. The Dixons are looking to provide the community with a one-stop shop for downsizing, moving, and liquidation services during some of the most trying times of people’s lives.

Caring Transitions is a franchise designed to minimize stress by utilizing specially trained professionals to oversee every detail of a senior’s transition with compassion, including decluttering, organizing, packing, move management, unpacking, resettling, and cleanouts. The company also manages both in-home and online estate sales. The online estate sales are hosted on CTBIDS, the brand’s widely popular auction platform, which can support its clients in liquidating unique, everyday treasures that many cherish.

The Dixons understand the challenge of clearing out your own belongings. Years ago, they found themselves liquidating their possessions to make ends meet. During that time, they also began attending yard sales and realizing they could profit by upselling items they’d buy. Now, 15 years later, Kevin runs a successful retail resale business. Caring Transitions of Costa Mesa is an extension of his experience and knowhow.

“Our clients might be going through some of the toughest moments of their life, grieving the loss of a loved one,” Kevin said. “Our job is to come in and take the task of packing and selling belongings off their hands and give them the space to grieve. In the end, we hope to return a little cash to their pockets that they could use to pay for a funeral or other expenses.”

In addition to benefiting clients’ wallets, the resale of belongings also helps the environment. Items stay out of landfills by keeping them in circulation.

“I’m excited to find the value in people’s treasures that they’ve been collecting their entire lives,” Jennifer confessed. “We’re here to simplify the process and keep our customers from feeling overwhelmed by the task at hand.”

While Kevin runs the retail resale business, Jennifer has extensive banking, finance, and customer service background. The two are also notary publics, where they meet many people handling trusts and wills. They now hope to extend their services to those individuals by helping them through the liquidation process.

“Jennifer and Kevin will make a huge impact on their community by providing top-tier transition services,” said Ray Fabik, President of Caring Transitions. “Their business, finance, and customer service backgrounds combined with their passion for helping others make them the perfect fit for our franchise.”

Caring Transitions currently has more than 250 franchise locations serving families across the country.

To learn more about Caring Transitions, visit http://www.CaringTransitions.com.

For more about franchising opportunities with Caring Transitions, visit https://www.caringtransitionsfranchise.com/

About Caring Transitions

Caring Transitions, founded in 2006, is the most trusted and experienced national franchise specializing in senior relocation and transition services. With more than 250 locations throughout the United States, all owned and operated by Certified Relocation and Transition Specialists, Caring Transitions provides clients with supportive moves, auctions, rightsizing, and transitions. This includes expert advice plus a well-executed transition plan beginning with the initial sorting of personal belongings through packing, unpacking, resettling, and selling of items to the final clearing and cleaning of the property. For more information, visit http://www.caringtransitions.com or visit us on Facebook.

Share article on social media or email:

OpenBOM and Orcanos Announces Partnership to Help Develop Modern SaaS Integrated PLM+QMS systems


PLM and QMS for medical companies

OpenBOM and Orcanos

“Cloud-native PLM and QMS systems are coming to the tipping point to help manufacturers to deliver better products faster and to comply with complex regulatory requirements,” says Oleg Shilovitsky, CEO and co-founder of OpenBOM.

OpenBOM™, a leading SaaS digital product data management, and collaboration platform announced a partnership with Orcanos, a leading provider of integrated ALM and QMS solutions, to provide an integrated SaaS PLM & QMS solution for medical device manufacturers and healthcare providers.

The healthcare industry continues to evolve, and medical device companies must ensure that their engineering and quality management processes can keep up with the fast pace of digital innovation. Business optimization strategies must now align with the technology available, replacing archaic paper-based systems and spreadsheets with tools that provide a single view of the relevant information.

“We are coming to a critical point in the digital transformation of manufacturing companies demanding to replace old fashion “analog” and siloed Excel document-driven processes with modern digital solutions. It can be achieved by using SaaS platforms capable of capturing information and ensuring streamlining processes, organizing data, and optimizing data handover during product development and manufacturing.” said Oleg Shilovitsky, CEO and co-founder of OpenBOM. “Cloud-native PLM and QMS systems are coming to the tipping point to help manufacturers to deliver better products faster and to comply with complex regulatory requirements,” he added.

“A key to compliance in the digital age is removing paper-based quality information and integrating automated and optimized solutions. Required reporting elements such as DMS, e-DHR, Complaints Management, FMEA Risk Management, CAPA, ECO, and Non-Conformities, can be monitored in an integrated cloud environment with engineering for Verification and Validation (including Requirements Management, Test Management, and Defect Tracking),” said Rami Azulay, co-founder, and CMO of Orcanos.

About Orcanos.

Founded in 2005, Orcanos Software has built its reputation on delivering integrated solutions that ease the time-to-market product hurdles that are part of the Quality Journey. In fact, Orcanos is the only vendor that provides an integrated software solution for Application Lifecycle Management (ALM, aka Design Control) and Quality Management Systems (QMS), which includes regulatory compliance, with a specialized focus on the medical device industry.

As a result, Orcanos has years of proven experience and innovation in a regulated and increasingly high-tech industry. Our team has honed their skills by working with medical device manufacturers and other high-tech companies, not only assisting them in building their operational excellence capabilities but also ensuring that the product lifecycle proceeds on a smooth path from day one. Headquarters in the industrial suburbs of Tel-Aviv, Orcanos website, is orcanos.com. For more information and questions, please contact sales@orcanos.com.

About OpenBOM

OpenBOM is a cloud-native PDM and PLM platform that manages product data and connects manufacturers and their supply chain networks. OpenBOM’s modern SaaS real-time collaboration and data management technology allows the creation and management of CAD files, Parts, Bill of Materials, Vendors, and Purchases across networks of engineers, supply chain managers, and contract manufacturers. OpenBOM enables people to share and collaborate using an online Bill of Materials from initial design through all stages of engineering, manufacturing, and supply chain. Headquartered in the Boston, MA area, OpenBOM’s website is http://www.openbom.com. For more information or questions please contact oleg(at)OpenBOM(dot)com. OpenBOM is a wholly-owned and branded product of Newman Cloud, Inc

Share article on social media or email:

Recosoft ships PDF2ID Professional Suite 2023


Converting PDF to InDesign and PowerPoint to InDesign in 1 package

Workflow automation tools for Adobe Creative Cloud users in 1 software product

PDF2ID Professional Suite provides Creative Professionals with the necessary tools solving their PDF-to-InDesign conversion, PowerPoint-to-InDesign conversion and PDF image and graphics assets extraction needs – Paramjit Chadha, MD, Recosoft Corporation

PDF2ID Professional Suite 2023 bundles essential workflow automation tools for Creative Professional in a single unified package resolving everyday PDF-to-InDesign, PowerPoint-to-InDesign, and graphics asset extraction from PDF files in a single package.

Key Features


  • Integrated workflow automation tools for Creative Professionals


PDF2ID Suite includes PDF2ID Professional 2023, the PDF-to-InDesign plug-in, DecksMoveIn 2023, the PowerPoint-to-InDesign tool and PDF2Assets* 2023, the image and graphics assets extraction application for PDF files in one package.

  • Supports latest version of Adobe Creative Cloud


PDF2ID Suite 2023 supports the latest tools in the Adobe Creative Cloud platform.

  • macOS and Windows platform support


PDF2ID Suite 2023 is available for both the macOS and Windows platforms supporting the latest versions of the respective operating systems.

PDF2ID Professional Suite is available in the following configurations:

PDF2ID Professional Suite 2023 for macOS – US$299 annual subscription

PDF2ID Professional Suite 2023 for Windows – US$299 annual subscription

System Requirements

Mac OS: macOS 10.15.x or higher

Hardware: Apple Silicon or Intel based Mac

Application: Adobe InDesign 2021 or higher

Windows: Windows 10, Windows 11

Hardware: Minimum Pentium III computer

Application: Adobe InDesign 2021 or higher

Recosoft Corporation has pioneered PDF2Office®, the de-facto PDF-to-Excel, PDF-to-Word, PDF-to-PowerPoint, PDF-to-OmniGraffle conversion utility; PDF2Office® for iWork, the PDF-to-Keynote, PDF-to-Numbers and PDF-to-Pages conversion application; IR2Office, the only Adobe Illustrator to PowerPoint and Apple Keynote tool; ID2Office, the InDesign-to-Word, InDesign-to-PowerPoint converter; and PDF2ID® the de-facto PDF-to-InDesign conversion tool. The company is a leader in designing and delivering PDF converters, InDesign and Illustrator software solutions enhancing workflow automation and productivity. For more information on Recosoft PDF converters and InDesign or Illustrator related solutions, visit http://www.recosoft.com

*PDF2Assets is initially only available for macOS

Contact Information

Recosoft Corporation

Hommachi 1-5-6, Chuo-ku,

Osaka, Japan

Fax: +81-6-6260-5543

http://www.recosoft.com

©Copyright 2022 Recosoft Corporation

PDF2Assets, DecksMoveIn, IR2Office, ID2Office, PDF2Office, PDF2ID, PDFtoID are trademarks or registered trademarks of Recosoft Corporation in the US and/or other countries. Microsoft, Excel, PowerPoint, Word, and the Office logo are trademarks or registered trademarks of Microsoft Corporation in the US and/or other countries. Adobe, InDesign, Illustrator and Creative Cloud are either registered trademarks or trademarks of Adobe System Incorporated in the US and/or other countries. Apple, Macintosh, macOS, Mac, Numbers, Keynote, Pages, iWork, iPod, iPhone, iOS, iPAD are either trademarks or registered trademarks of Apple, Inc. in the US and or other countries. All other trademarks are recognized and are the property of their respective owners.

Share article on social media or email:

Molecular Devices adds proprietary patient-derived organoid technology with acquisition of Cellesce


First-of-its-kind technology from Cellesce creates consistent patient-derived organoids for large scale drug screening

We’re excited to bring our domain expertise and intellectual property to Molecular Devices, together maximizing impact for customers in revolutionizing drug discovery and unlocking the full potential of human-relevant 3D biology research.

Molecular Devices, LLC., a leading provider of high-performance life science solutions, today announced the acquisition of Cellesce Ltd (“Cellesce”) which specializes in contract development and manufacturing of large scale patient-derived organoids (PDOs) for diverse applications, including drug screening.

Drug efficacy and toxicity testing often rely on immortalized cell lines or animal models that don’t closely mimic complex human biology. This can lead to inaccurate predictions of a drug’s potential and extended drug development timelines. However, a number of retrospective studies confirm a high degree of similarity between the phenotype and genotype of a PDO and an original patient tumor, showing that if a drug worked on the PDO, it was 90 percent likely to work on the patient. This acquisition of Cellesce affirms Molecular Devices’ commitment to investing in 3D biology technologies that transform the drug discovery process and drive development of novel therapeutics.

“By combining Cellesce’s expertise in producing industrial-scale PDOs with Molecular Devices’ market-leading end-to-end solutions for automated organoid screening, we will enable customers to accomplish advanced 3D biology research with a commercial offering that’s never been available before from one provider,” said Susan Murphy, President of Molecular Devices. “This enabling technology will make over 100,000 compound primary screens with PDOs a reality and will accelerate industry adoption of organoids.”

Headquartered in Cardiff, Wales, and backed by a team of scientists, engineers, and manufacturing technicians, Cellesce technology produces uniform, human-derived cell or organoid lines including off-the-shelf colorectal cancer, gastrointestinal, and breast cancer organoids — with pancreatic and lung organoids under development — all at a scale unmatched by any commercial technology available today. The company’s quality-assured, patented bioprocess workflow and unique bioreactors have been proven to increase productivity 20- to 60-fold.

“Molecular Devices has the capability, reputation, reach, and resources to ensure that the Cellesce technology can be further developed, and used to its full potential,” said Vicky Marsh-Durban, CEO of Cellesce. “We’re excited to bring our domain expertise and intellectual property to Molecular Devices, together maximizing impact for customers in revolutionizing drug discovery and unlocking the full potential of human-relevant 3D biology research.”

For more information on the promise of organoids for advanced drug discovery, visit http://www.moleculardevices.com.

About Molecular Devices, LLC.

Molecular Devices is one of the world’s leading providers of high-performance bioanalytical measurement systems, software and consumables for life science research, pharmaceutical and biotherapeutic development. Included within a broad product portfolio are platforms for high-throughput screening, genomic and cellular analysis, colony selection and microplate detection. These leading-edge products enable scientists to improve productivity and effectiveness, ultimately accelerating research and the discovery of new therapeutics. Molecular Devices is committed to the continual development of innovative solutions for life science applications. The company is headquartered in Silicon Valley, California with offices around the globe. Visit Molecular Devices at http://www.moleculardevices.com.

About Cellesce

Based in Cardiff, Cellesce is a biotechnology company that has developed a patented bioprocessing technology for the growing on and expansion of organoids. Cellesce is focused on the supply of standardized and well characterized cancer organoids for large-scale applications such as compound screening, especially for high throughput screening requirements, where significant quantities of reproducible batches are required. Visit Cellesce at http://www.cellesce.com.

# # #

Share article on social media or email:

A Safe Place, Soul Survivors of Chicago, Stevenson Foundation


The SBB Research Group Foundation recognized three Chicago-area charities as the September 2022 finalists of its monthly grant program supporting impactful nonprofits (in alphabetical order):


  • A Safe Place (Zion) supports domestic violence and human trafficking survivors by providing comprehensive services that meet the immediate and long-term needs of victims and prevent future abuse.
  • Soul Survivors of Chicago (Olympia Fields) offers training, workshops, and speaking engagements to help youth struggling with mental health and trauma.
  • Stevenson Foundation (Lincolnshire) provides Stevenson community students and families with the resources and opportunities they need to reach their highest potential.

The Foundation encourages any 501(c)(3) nonprofit organization to apply for a grant at sbbrg.org/apply-for-grant. Donations are awarded to different organizations monthly.

About the SBB Research Group Foundation

The SBB Research Group Foundation is a 501(c)(3) nonprofit that supports ambitious organizations solving unmet needs with thoughtful, long-term strategies. SBB Research Group LLC, a Chicago-based investment management firm led by Sam Barnett, Ph.D., and Matt Aven, established the SBB Research Group Foundation to further its philanthropic mission. In addition, the Foundation sponsors the SBBRG STEM Scholarship, which supports students pursuing science, technology, engineering, and mathematics degrees.

Share article on social media or email: